Separate names with a comma.
Discussion in 'Insys Therapeutics' started by anonymous, Jun 10, 2018 at 7:12 AM.
If the sales team does not produce by the end of this quarter layoffs are going to occur.
Threats threats... let’s see... layoffs for sales force so corporate execs, VPs, directors, and non-producing overpaid waste can collect bonuses, enjoy ‘team building’ events, and wait out the imminent closing of the door. Yep sounds about right
when are the layoffs?
My guess early July, maybe end of June...no way does insys survive.
Yes they can - if they shave off the excess managerial fat
That's not going to happen.. Losing 20 million dollars a quarter doesn't say much for our sales. Companies don't survive losing money every quarter
Yes, I agree on the layoffs. Think about it, previous Subsys sales were due to off label promotion and now with on label promotion the patient population is minimal and very niched. Many physicians don't want anything to do with a tainted company. Syndros sales are so slow and managed care is a nightmare. Next, we don't know when or how much the fine is going be. Finally, our pipeline is being rejected by the FDA. Where would the money come from to sustain the fines that are coming. The whole thing is a mess.